Last update 01 Nov 2024

KEAP1 x Nrf2 x IFNβ x IL-6 x TET2

Basic Info

Related Targets
KEAP1Nrf2IFNβ[+2]

Related

1
Drugs associated with KEAP1 x Nrf2 x IFNβ x IL-6 x TET2
SCD-153
Target
IFNβ x IL-6 x KEAP1 x Nrf2 x TET2
Mechanism
IFNβ inhibitors [+4]
Active Org.
Sun Pharma Advanced Research Co. Ltd. [+2]
Originator Org.
Sun Pharma Advanced Research Co. Ltd.
Active Indication
Alopecia Areata
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with KEAP1 x Nrf2 x IFNβ x IL-6 x TET2
CTRI/2023/10/059183 / CompletedPhase 1
A Randomized, Double-Blind, Vehicle-Controlled, Study to Evaluate the Safety, Tolerability, & Pharmacokinetics of topically applied SCD-153 in Healthy Volunteers - Nil
100 Clinical Results associated with KEAP1 x Nrf2 x IFNβ x IL-6 x TET2
Login to view more data
100 Translational Medicine associated with KEAP1 x Nrf2 x IFNβ x IL-6 x TET2
Login to view more data
0 Patents (Medical) associated with KEAP1 x Nrf2 x IFNβ x IL-6 x TET2
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free